Cargando…

Expression Profiles of Long Non-Coding RNA GAS5 and MicroRNA-222 in Younger AML Patients

Acute myeloid leukemia (AML) is a heterogeneous malignant disease both on clinical and genetic levels. AML has poor prognosis and, therefore, there is a constant need to find new prognostic markers, as well as markers that can be used as targets for innovative therapeutics. Recently, the search for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pavlovic, Djordje, Tosic, Natasa, Zukic, Branka, Pravdic, Zlatko, Vukovic, Nada Suvajdzic, Pavlovic, Sonja, Gasic, Vladimir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774494/ https://www.ncbi.nlm.nih.gov/pubmed/35054253 http://dx.doi.org/10.3390/diagnostics12010086

Ejemplares similares

The influence of BCL2, BAX, and ABCB1 gene expression on prognosis of adult de novo acute myeloid leukemia with normal karyotype patients
por: Pravdic, Zlatko, et al.
Publicado: (2023)

Diagnostic and Therapeutic Implications of Long Non-Coding RNAs in Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2022)

PB1776: EXPRESSION OF BCL2, BAX AND MDR1 GENES AS PHARMACOTRANSCRIPTOMIC MARKERS OF PROGNOSIS IN DE NOVO PATIENTS OF ADULT ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE
por: Gašić, Vladimir, et al.
Publicado: (2023)

PB1821: THE INFLUENCE OF BCL2, BAX, BAX/BCL2 RATIO AND MDR1 GENE EXPRESSION ON PROGNOSIS OF ADULT DE NOVO ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE
por: Pravdic, Zlatko, et al.
Publicado: (2023)

Expression Pattern of Long Non-coding RNA Growth Arrest-specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2019)

Somatic mutations of isocitrate dehydrogenases 1 and 2 are prognostic and follow-up markers in patients with acute myeloid leukaemia with normal karyotype
por: Virijevic, Marijana, et al.
Publicado: (2016)

Pharmacogenomic and Pharmacotranscriptomic Profiling of Childhood Acute Lymphoblastic Leukemia: Paving the Way to Personalized Treatment
por: Pavlovic, Sonja, et al.
Publicado: (2019)

Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications
por: Stankovic, Biljana, et al.
Publicado: (2021)

A gene expression profile associated with relapse of cytogenetically normal acute myeloid leukemia is enriched for leukemia stem cell genes
por: Hackl, Hubert, et al.
Publicado: (2015)

Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection
por: Klaassen, Kristel, et al.
Publicado: (2020)

PB1917: EXPRESSION OF THE LONG NON-CODING RNA MALAT1 IN CHRONIC LYMPHOCYTIC LEUKEMIA
por: Karan-Đurašević, Teodora, et al.
Publicado: (2023)

Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?
por: Jelovac, Marina, et al.
Publicado: (2023)

PB2582: WHY INFECTIOUS COMPLICATIONS ARE STILL THE MAIN CAUSE OF MORTALITY DURING THE TREATMENT OF PATIENTS WITH ACUTE LEUKEMIA?
por: Vidovic, Ana, et al.
Publicado: (2023)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
por: Stanković, Biljana, et al.
Publicado: (2020)

Significance of UGT1A1*28 Genotype in Patients with Advanced Liver Injury Caused By Chronic Hepatitis C
por: Jordovic, Jelena, et al.
Publicado: (2019)

Pharmacogenomic Markers of Glucocorticoid Response in The Initial Phase of Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia
por: Gasic, Vladimir, et al.
Publicado: (2018)

Pharmacogenomic Markers of Methotrexate Response in the Consolidation Phase of Pediatric Acute Lymphoblastic Leukemia Treatment
por: Kotur, Nikola, et al.
Publicado: (2020)

Application of targeted next generation sequencing for the mutational profiling of patients with acute lymphoblastic leukemia
por: Janic, Dragana, et al.
Publicado: (2020)

The Role of the Spleen and the Place of Splenectomy in Autoimmune Hemolytic Anemia—A Review of Current Knowledge
por: Cvetković, Zorica, et al.
Publicado: (2023)

PB2632: DILLEMAS AND CHALLENGES IN ITP TREATMENT OF A PATIENT WITH THROMBOTIC AND HEMORRHAGIC EVENTS DEVELOPMENT
por: Smiljanic, Mihailo, et al.
Publicado: (2023)

Genome-Wide Association Study of COVID-19 Outcomes Reveals Novel Host Genetic Risk Loci in the Serbian Population
por: Zecevic, Marko, et al.
Publicado: (2022)

Immunoglobulin Heavy Chain Gene Rearrangements in Patients with Gaucher Disease
por: Rodić, Predrag, et al.
Publicado: (2018)

PB2037: NEW TERT VARIANT IN A FAMILY WITH APLASTIC ANEMIA
por: Virijevic, Marijana, et al.
Publicado: (2023)

Association of Vitamin D, Zinc and Selenium Related Genetic Variants With COVID-19 Disease Severity
por: Kotur, Nikola, et al.
Publicado: (2021)

6th Golden Helix Pharmacogenomics Day: pharmacogenomics and individualized therapy
por: Stojiljkovic, Maja, et al.
Publicado: (2012)

UGT1A1 (TA)(n) Promoter Genotype: Diagnostic and Population Pharmacogenetic Marker in Serbia
por: Vukovic, M, et al.
Publicado: (2018)

Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia
por: Milosevic, Goran, et al.
Publicado: (2018)

S308: RISK FACTORS FOR VENOUS THROMBOEMBOLISM IN ACUTE PROMYELOCYTIC LEUKEMIA
por: Sabljic, Nikica, et al.
Publicado: (2023)

Arterial Thrombosis in Patients with Acute Myeloid Leukemia: Incidence and Risk Factors
por: Mitrovic, Mirjana, et al.
Publicado: (2023)

P1655: DEEP VENOUS THROMBOSIS IN PATIENT WITH ATRESIA OF INFERIOR VENA CAVA AND RIGHT KIDNEY HYPOPLASIA (KILT SYNDROME): CASE REPORT AND SYSTEMATIC REVIEW OF THE LITERATURE
por: Pantic, Nikola, et al.
Publicado: (2023)

The first insight into the genetic structure of the population of modern Serbia
por: Drljaca, Tamara, et al.
Publicado: (2021)

Association of Bax Expression and Bcl2/Bax Ratio with Clinical and Molecular Prognostic Markers in Chronic Lymphocytic Leukemia
por: Vucicevic, Ksenija, et al.
Publicado: (2016)

Renal function in living related kidney donors above the age of 70
por: Milic, V, et al.
Publicado: (2010)

Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia
por: Sabljic, Nikica, et al.
Publicado: (2022)

MicroRNA-222 Regulates Melanoma Plasticity
por: Lionetti, Maria Chiara, et al.
Publicado: (2020)

Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation
por: Jurišić, Vladimir, et al.
Publicado: (2018)

Altered Root Growth, Auxin Metabolism and Distribution in Arabidopsis thaliana Exposed to Salt and Osmotic Stress
por: Smolko, Ana, et al.
Publicado: (2021)

A Prognostic Autophagy-Related Long Non-coding RNA (ARlncRNA) Signature in Acute Myeloid Leukemia (AML)
por: Zhao, Chunxia, et al.
Publicado: (2021)

Cost comparison of post-remission strategies in younger and older AML patients in France
por: Mounie, Michael, et al.
Publicado: (2023)

Association of social deprivation with survival in younger adult patients with AML: an Alliance study
por: Rebechi, Melanie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3up8rba35cq0da49d1o9ksnc26